SEC Form 3 · accession 0001615774-19-002595
Hoth Therapeutics, Inc. · RKTO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth L Rice Jr.
Director
Period of report
Feb 14, 2019
Accepted (ET)
Feb 15, 2019 · 7:44 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001711786
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 50,000 | D | ||
| Common StockF1 | holding | — | — | — | 726,943 | I | see footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities are owned by Chelexa Biosciences, Inc. ("Chelexa"). Kenneth Rice is the Executive Chairman of Chelexa and in such capacity has voting and dispositive power of the securities held by such entity.
Remarks
Exhibit 24 - Powers of Attorney